Nymox Pharmaceutical
NYMX
#9954
Rank
NZ$31.78 M
Marketcap
Country
$0.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -NZ$3.76 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$11.37 Million, an increase over its 2021 earnings that were of -NZ$21.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$3.76 Million-66.93%
2022 -NZ$11.37 Million-47.71%
2021 -NZ$21.74 Million6.61%
2020 -NZ$20.39 Million-10.91%
2019 -NZ$22.89 Million24.24%
2018 -NZ$18.42 Million-20.03%
2017 -NZ$23.04 Million2.71%
2016 -NZ$22.43 Million-63.86%
2015 -NZ$62.06 Million674.44%
2014 -NZ$8.02 Million-6.11%
2013 -NZ$8.54 Million-35.66%
2012 -NZ$13.27 Million-20.76%
2011 -NZ$16.75 Million38.33%
2010 -NZ$12.11 Million35.59%
2009 -NZ$8.93 Million11.8%
2008 -NZ$7.99 Million-12.94%
2007 -NZ$9.17 Million8.85%
2006 -NZ$8.43 Million36.5%
2005 -NZ$6.18 Million-4.4%
2004 -NZ$6.46 Million-14.58%
2003 -NZ$7.56 Million
2001 -NZ$5.55 Million-20.54%
2000 -NZ$6.98 Million21.72%
1999 -NZ$5.74 Million-25.56%
1998 -NZ$7.71 Million101.3%
1997 -NZ$3.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.21 B-324,625.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.35 B-514,352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.04 B-54,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.08 B-586,883.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.37 B-807,226.33%๐Ÿ‡บ๐Ÿ‡ธ USA